Home/Filings/4/0001209191-19-015533
4//SEC Filing

Fordham Benjamin C 4

Accession 0001209191-19-015533

CIK 0001108109other

Filed

Mar 3, 7:00 PM ET

Accepted

Mar 4, 4:10 PM ET

Size

16.0 KB

Accession

0001209191-19-015533

Insider Transaction Report

Form 4
Period: 2019-03-01
Fordham Benjamin C
EVP and General Counsel
Transactions
  • Award

    Performance Based Restricted

    2019-03-01+52,50052,500 total
    Exercise: $0.00Common Stock (52,500 underlying)
  • Award

    Common Stock

    2019-03-01+26,250146,879 total
  • Tax Payment

    Common Stock

    2019-03-01$4.99/sh9,839$49,097137,040 total
  • Award

    Stock Options (Right to Buy)

    2019-03-01+26,25026,250 total
    Exercise: $4.99From: 2020-03-01Exp: 2029-02-28Common Stock (26,250 underlying)
Holdings
  • Performance Based Restricted

    Exercise: $0.00Common Stock (35,000 underlying)
    35,000
  • Performance Based Restricted

    Exercise: $0.00Common Stock (20,000 underlying)
    20,000
Footnotes (5)
  • [F1]The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant.
  • [F2]The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2019 and 12/31/2021 (the "2019-2021 Performance Period"), as follows: 50% to a Cumulative Same-Store Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2019-2021 Performance Period.
  • [F3]Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant.
  • [F4]The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2017 and 12/31/2019 (the "2017-2019 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2017-2019 Performance Period.
  • [F5]The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2018 and 12/31/2020 (the "2018-2020 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2018-2020 Performance Period.

Issuer

COMMUNITY HEALTH SYSTEMS INC

CIK 0001108109

Entity typeother

Related Parties

1
  • filerCIK 0001700942

Filing Metadata

Form type
4
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 4:10 PM ET
Size
16.0 KB